Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

Cancers
Catalina AlamónHugo Cerecetto

Abstract

Malignant gliomas are the most common malignant and aggressive primary brain tumors in adults, the prognosis being-especially for glioblastomas-extremely poor. There are no effective treatments yet. However, tyrosine kinase receptor (TKR) inhibitors and boron neutron capture therapy (BNCT), together, have been proposed as future therapeutic strategies. In this sense in our ongoing project of developing new anti-glioblastoma drugs, we identified a sunitinib-carborane hybrid agent, 1, with both in vitro selective cytotoxicity and excellent BNCT-behavior. Consequently, we studied the ability of compound 1 to inhibit TKRs, its promotion of cellular death processes, and its effects on the cell cycle. Moreover, we analyzed some relevant drug-like properties of 1, i.e., mutagenicity and ability to cross the blood-brain barrier. These results encouraged us to perform an in vivo anti-glioblastoma proof of concept assay. It turned out to be a selective FLT3, KIT, and PDGFR-β inhibitor and increased the apoptotic glioma-cell numbers and arrested sub-G1-phase cell cycle. Its in vivo activity in immunosuppressed mice bearing U87 MG human glioblastoma evidenced excellent anti-tumor behavior.

References

Jul 26, 2002·Journal of the American Chemical Society·Alessandro DonatiClaudio Rossi
Aug 15, 2002·Blood·D Gary Gilliland, James D Griffin
Feb 1, 2003·Current Drug Targets·Joachim DrevsClemens Unger
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 16, 2007·Journal of Chemical Information and Modeling·Junmei WangXiaojie Xu
Jul 12, 2007·Neuro-oncology·Sophie de BoüardJean-Sébastien Guillamo
Jan 10, 2008·Nature Biotechnology·Mazen W KaramanPatrick P Zarrinkar
Jul 19, 2008·Lancet Neurology·Andrew I R MaasRoss Bullock
Sep 26, 2008·Molecular Pharmacology·Brian B HasinoffKimberley A O'Hara
Jun 9, 2009·Brain Research·Katayun Cohen-Kashi MalinaVivian I Teichberg
Jul 16, 2009·Investigational New Drugs·Efstathia GiannopoulouHaralabos P Kalofonos
Oct 23, 2009·Chemical Research in Toxicology·Hao ZhuAlexander Tropsha
Nov 10, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Georgios S Papaetis, Kostas N Syrigos
Jan 23, 2010·Nature Reviews. Cancer·Zachary A KnightKevan M Shokat
Feb 18, 2009·Clinical and Translational Science·Risto KerkelaThomas Force
Jun 29, 2010·Journal of Chemical Information and Modeling·Jie ShenYun Tang
Apr 21, 2011·The Journal of Pathology·Hiroko NagaoTakao Setoguchi
Jul 26, 2011·Chemical Reviews·Matthias Scholz, Evamarie Hey-Hawkins
Oct 25, 2012·Journal of Chemical Information and Modeling·Feixiong ChengYun Tang
Jun 25, 2013·Magnetic Resonance Imaging·Nelly GordilloPilar Sobrevilla
Aug 14, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy T BatchelorMartin van den Bent
Nov 1, 2013·Chemical Society Reviews·Eric W Price, Chris Orvig
Jul 17, 2014·Journal of Medicinal Chemistry·N V S Dinesh K BhupathirajuM Graça H Vicente
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Feb 26, 2016·Journal of the American Chemical Society·Xiaolei ZhangDieter Cremer
Apr 28, 2016·Chemistry : a European Journal·Jordi PoaterFrancesc Teixidor
Mar 6, 2017·Critical Reviews in Oncology/hematology·Giuseppe LombardiVittorina Zagonel
Jun 13, 2017·Chemistry : a European Journal·Marcos CoutoClara Viñas
May 29, 2018·Clinical Neurology and Neurosurgery·C Rory GoodwinBachchu Lal
Sep 22, 2018·Glia·Mayra BrandaoGeorgios Giamas
Mar 14, 2019·Molecular Pharmaceutics·Juan Aparicio-BlancoAna I Torres-Suárez
Apr 11, 2019·Journal of Neuroinflammation·Zhuangzhuang ChenGuozhong Li
May 7, 2019·Journal of Visualized Experiments : JoVE·Vadim Le JoncourPirjo Maarit Laakkonen

❮ Previous
Next ❯

Citations

Jan 21, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vera V VoinovaNikolay T Kuznetsov

❮ Previous
Next ❯

Methods Mentioned

BETA
confocal microscopy
flow cytometry
bioluminescence
Assay
FACS
bioluminescence imaging

Software Mentioned

BD FACSDiva
ChemDraw Standard
GraphPad
GraphPad Prism
Living Image
Attune NxT
FlowJo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.